These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11219570

  • 1. Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication?
    Weismantel D.
    J Fam Pract; 2001 Feb; 50(2):181. PubMed ID: 11219570
    [No Abstract] [Full Text] [Related]

  • 2. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM, Su SF, Tsai CH, Lee YT, Wang SS.
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [Abstract] [Full Text] [Related]

  • 3. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF, Davie AM, Clegg JP.
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [Abstract] [Full Text] [Related]

  • 4. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL, Zheng Q, Worthy SA, Charles B, Bradley DV.
    Angiology; 2002 Jun; 53(5):509-20. PubMed ID: 12365857
    [Abstract] [Full Text] [Related]

  • 5. Treatment of intermittent claudication: cilostazol.
    Collins P, Brittenden J.
    Hosp Med; 2004 Aug; 65(8):466-70. PubMed ID: 15330347
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of cilostazol and other therapies for intermittent claudication.
    Dawson DL.
    Am J Cardiol; 2001 Jun 28; 87(12A):19D-27D. PubMed ID: 11434896
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of cilostazol, naftidrofuryl oxalate, and pentoxifylline for the treatment of intermittent claudication in people with peripheral arterial disease.
    Meng Y, Squires H, Stevens JW, Simpson E, Harnan S, Thomas S, Michaels J, Stansby G, O'Donnell ME.
    Angiology; 2014 Mar 28; 65(3):190-7. PubMed ID: 23378195
    [Abstract] [Full Text] [Related]

  • 8. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
    Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.
    Br J Surg; 2012 Dec 28; 99(12):1630-8. PubMed ID: 23034699
    [Abstract] [Full Text] [Related]

  • 9. A comparison of cilostazol and pentoxifylline for treating intermittent claudication.
    Dawson DL, Cutler BS, Hiatt WR, Hobson RW, Martin JD, Bortey EB, Forbes WP, Strandness DE.
    Am J Med; 2000 Nov 28; 109(7):523-30. PubMed ID: 11063952
    [Abstract] [Full Text] [Related]

  • 10. Effects of cilostazol and pentoxifylline on forearm reactive hyperemia response, lipid profile, oxidative stress, and inflammatory markers in patients with intermittent claudication.
    de Albuquerque RM, Virgini-Magalhães CE, Lencastre Sicuro F, Bottino DA, Bouskela E.
    Angiology; 2008 Nov 28; 59(5):549-58. PubMed ID: 18388031
    [Abstract] [Full Text] [Related]

  • 11. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Roset PN.
    Br J Surg; 2013 Dec 28; 100(13):1838. PubMed ID: 24227374
    [No Abstract] [Full Text] [Related]

  • 12. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL, DeMaioribus CA, Hagino RT, Light JT, Bradley DV, Britt KE, Charles BE.
    Am J Surg; 1999 Aug 28; 178(2):141-6. PubMed ID: 10487267
    [Abstract] [Full Text] [Related]

  • 13. Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).
    Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G.
    Br J Surg; 2013 Dec 28; 100(13):1838-9. PubMed ID: 24227373
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of intermittent claudication with pentoxifylline and cilostazol.
    Tjon JA, Riemann LE.
    Am J Health Syst Pharm; 2001 Mar 15; 58(6):485-93; quiz 494-6. PubMed ID: 11286146
    [Abstract] [Full Text] [Related]

  • 15. Drug treatment of intermittent claudication.
    Jacoby D, Mohler ER.
    Drugs; 2004 Mar 15; 64(15):1657-70. PubMed ID: 15257627
    [Abstract] [Full Text] [Related]

  • 16. Cilostazol in intermittent claudication.
    Cariski AT, Lindmayer K.
    Am J Health Syst Pharm; 2002 Jan 01; 59(1):81-2. PubMed ID: 11813475
    [No Abstract] [Full Text] [Related]

  • 17. Differential lipogenic effects of cilostazol and pentoxifylline in patients with intermittent claudication: potential role for interleukin-6.
    Lee TM, Su SF, Hwang JJ, Tseng CD, Chen MF, Lee YT, Wang SS.
    Atherosclerosis; 2001 Oct 01; 158(2):471-6. PubMed ID: 11583728
    [Abstract] [Full Text] [Related]

  • 18. Treatment with pharmacological agents in peripheral arterial disease patients does not result in biomechanical gait changes.
    Huisinga JM, Pipinos II, Stergiou N, Johanning JM.
    J Appl Biomech; 2010 Aug 01; 26(3):341-8. PubMed ID: 20841626
    [Abstract] [Full Text] [Related]

  • 19. Cilostazol: new drug. Intermittent claudication: too little efficacy, too many risks.
    Prescrire Int; 2009 Apr 01; 18(100):56-9. PubMed ID: 19585717
    [Abstract] [Full Text] [Related]

  • 20. Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial.
    De Sanctis MT, Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, Incandela L, Bucci M, Geroulakos G, Ramaswami G, Vasdekis S, Agus G, Bavera P, Ippolito E.
    Angiology; 2002 Apr 01; 53 Suppl 1():S13-7. PubMed ID: 11865829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.